Enhertu approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow...

TROPION-Lung12 phase 3 trial initiated evaluating DATROWAY as part of adjuvant regimen for patients with...

Tubulis Announces First Patient Dosed in Phase I/IIa Trial Evaluating ADC TUB-030 in Advanced Solid...

Vincerx Pharma, Inc. and Oqory, Inc. highlight promising data for Oqory’s TROP2 ADC , OQY-3258

Innate Pharma announces first patient dosed in phase 1 study of its Nectin-4 targeting antibody...

Lantern Pharma unveils innovative AI-Powered module to improve the precision, cost and timelines of Antibody-Drug...